VivoSim Labs, INC. (NASDAQ:VIVS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 11, 2026.
The Healthcare company reported Q0 revenue of .
VivoSim Labs, INC.'s stock currently trades at $1.92 with a market capitalization of $5.8M.